Company: AEMD
Filing Date: 2025-04-18
Form Type: DEF 14A
Source: 0001683168-25-002685
Chunk: 31

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-18
Form: DEF 14A
Chunk 31
---
, LOCAL AND NON-U.S. TAX LAWS.

Required Vote

The Reverse Stock Split would
be effectuated pursuant to NRS 78.2055, which was amended by the Nevada Legislature effective May 30, 2023, pursuant to Assembly Bill
No. 126. Pursuant to such amendment, the Reverse Stock Split will be approved, in accordance with our amended and restated bylaws, if
more votes are cast in favor of this proposal than are cast against it. Abstentions and broker non-votes on this proposal will have no
effect on the outcome.

As noted above, in the event that our stockholders do not approve this Proposal 1, our Board of Directors may take action in accordance with NRS 78.207 to effect a reverse split of our common stock without stockholder approval if required to comply with the Nasdaq minimum bid price requirement and if deemed to be in the interest of the Company.

<div align='center'>OUR BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE APPROVAL OF A REVERSE STOCK SPLIT AS SET FORTH IN PROPOSAL 1.</div>

| 16 |

<div align='center'>PROPOSAL NO. 2 - To approve the issuance of shares of common stock upon exercise of Inducement Warrants issued in a private placement, and to approve the Reset of Exercise Price provision contained in the Inducement Warrants.</div>

We are seeking stockholder approval, for
the issuance of up to 12,400,000 (subject to beneficial ownership limitations) shares of Common Stock issuable upon exercise of the Inducement
Warrants (defined below) and for approval of the Reset of Exercise Price provision found in Section 3(i) of the Inducement Warrants.

The information set forth in this Proposal
2 is qualified in its entirety by reference to the full text of Inducement Warrant (as defined below) and inducement offer (as defined
below) attached as exhibits 4.1 and 1013, respectively, to our Current Report on Form 8-K filed with the SEC on March 17, 2025.

Stockholders are urged to carefully read
these documents.

Background

On March 16, 2025, we entered into an inducement
offer to exercise existing Class A and Class B Warrants (the “Agreement”) with a certain accredited and institutional holder
(the “Holder”) of the